TipRanks on MSN
Incyte steps into late-stage colorectal cancer race with new phase 3 trial of INCA33890
Incyte ($INCY) announced an update on their ongoing clinical study. Study Overview Incyte’s new Phase 3 trial, titled “A Randomized, Double-Blind, ...
TipRanks on MSN
BMY and BNTX advance new immunotherapy bet in first-line liver cancer with ROSETTA HCC-206
Biontech Se Sponsored Adr (BNTX), Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback